Mint Tower Capital Management B.V.
Position in APLS — Apellis Pharmaceuticals, Inc.
CIK 1666606
AMSTERDAM, P7
Position in APLS
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$0
New position
Shares Held
22,000
first reported quarter
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Mint Tower Capital Management B.V. holds $14,963 across 10 Biotechnology names. APLS ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNA |
Atrium Therapeutics, Inc.
|
781 | $10,441 | |
| 2 | OSRH |
OSR Health, Inc.
|
82,500 | $4,522 | |
| 3 | OCS |
Oculis Holding AG
|
5,833 | $0 | |
| 4 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,200 | $0 | |
| 5 | ASBP |
Aspire Biopharma Holdings, Inc.
|
25,000 | $0 | |
| 6 | PBM |
Psyence Biomedical Ltd.
|
50,000 | $0 | |
| 7 | ACLX |
Arcellx, Inc.
|
12,000 | $0 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
This page
|
22,000 | $0 |
All Filings in APLS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 22,000 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||